Developing vaccines to prevent HIV-1 infection
NIAID Preclinical Development Support: Adjuvants for HIV-1 Vaccines
This study is working on new vaccines to help prevent HIV-1, the virus that causes AIDS, so that people can have better options for staying healthy and avoiding the virus in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-11041800 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new vaccines to prevent HIV-1, the virus that causes AIDS. It involves developing various types of vaccines, including DNA plasmids and viral vectors, and conducting preclinical tests to ensure their safety and effectiveness. The research aims to streamline the process of bringing these vaccines to human clinical trials by managing all aspects of development, production, and regulatory documentation. Patients may benefit from advancements in HIV prevention through improved vaccine options.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at high risk for HIV-1 infection or those interested in preventive measures against HIV.
Not a fit: Patients who are already living with HIV-1 may not receive direct benefits from this research focused on prevention.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the risk of HIV-1 infection.
How similar studies have performed: Previous research has shown promise in developing HIV vaccines, but this approach aims to enhance and expedite the process, making it a potentially novel advancement.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Vancott, Thomas — Advanced Bioscience Laboratories, INC.
- Study coordinator: Vancott, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.